Cincinnati Enquirer speaks with UC College of Medicine researcher about opioids and HIV
Jason Blackard, PhD, uses NIDA grant to find better therapies for addicts living with HIV
The Cincinnati Enquirer highlighted a $1.7 million National Institute of Drug Abuse (NIDA) grant awarded over a three-year period to Jason Blackard, PhD, to conduct an omics analysis of synthetic opioids and HIV. Blackard, an associate professor in the UC Department of Internal Medicine’s Division of Digestive Diseases, says opioids and HIV encourage one another and not in a good way.
Jennifer Brown, PhD, associate professor of psychiatry, a co-investigator on the study, also spoke with the Enquirer.
You can read the full news release here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.